Role of nonmuscle myosin IIA in sex-dependent failed repair mechanisms in acute kidney injury
非肌肉肌球蛋白 IIA 在急性肾损伤性别依赖性失败修复机制中的作用
基本信息
- 批准号:10311908
- 负责人:
- 金额:$ 6.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:ActinsAcuteAcute Renal Failure with Renal Papillary NecrosisAdhesionsAdoptedAffectAtlasesAutomobile DrivingBilateralBindingBinding ProteinsBiochemicalBiologicalBiological AssayBiologyCell Adhesion MoleculesCell NucleusCell PolarityCell ShapeCell modelCell physiologyCellsCenters for Disease Control and Prevention (U.S.)CharacteristicsChronic Kidney FailureCytokinesisCytoskeletonDataDisease ManagementDisease ProgressionDown-RegulationElementsEnd stage renal failureEventExhibitsFemaleFibrosisFilamentGenesGenetic MarkersGoldHealthcareHospitalizationHourIn VitroInflammationInjuryInjury to KidneyInvestigationIschemiaKidneyLaboratoriesLightLiverLungMapsMorphologyMusNonmuscle Myosin Type IIAOutcomePathway interactionsPatientsPhenotypePhosphorylationPhosphotransferasesPlayPopulationPre-Clinical ModelPrevalencePropertyRNARecoveryRegulationRenal functionReperfusion InjuryReportingRoleSepsisSerineSex DifferencesSignal PathwaySignal TransductionStructureSystemTechniquesThreonineTimeTissuesToxinTranslatingUnited StatesWomanXCL1 genecell motilitydifferential expressioneffective therapyepidemiologic datagenome wide association studyimprovedimproved outcomein vivoinjuredinjury and repairinsightischemic injurykidney cellmalemenmigrationmultimodalitynon-muscle myosinnovelprotective factorsprotein expressionrepairedresponserhosexsexual dimorphismstemtherapeutic targettherapeutically effectivetranscriptome sequencingtranscriptomics
项目摘要
ABSTRACT
The cellular mechanisms that drive the progression of acute kidney injury (AKI) to chronic kidney disease (CKD)
are not well understood. AKI is the abrupt decrease of kidney function from a variety of causes that elicits
structural and functional damage. The prevalence of AKI is increasing rapidly in the United States and presents
a healthcare burden worldwide. To date, there are no effective therapies for the mitigation of the proinflammatory
and fibrotic phenotypes resulting from injury. Interestingly, it has been recently supported with epidemiological
data that female sex is a protective factor in the AKI progression to CKD. Leveraging the comparison of sex
specific mechanisms in ischemic injury has incredible potential for the identification of novel, effective therapeutic
targets. Therefore, I will be employing single nuclei RNA and ATAC-Sequencing, as well as spatial
transcriptomics to generate a multimodal atlas of the injury time course in females undergoing bilateral ischemia
reperfusion injury (Bi-IRI). Recently, a novel cell state has been identified in male mice following Bi-IRI using
single nuclei RNA sequencing. Known as failed repair proximal tubule cells (FR-PTC), these cells represent a
dead end in the recovery pathway and could be lending a role to increases in proliferation, fibrosis, and
inflammation that worsen kidney tissue after injury. These FR-PTCs exhibit a profile of differentially expressed
genes that are unique from healthy and repairing cell states. One of these genetic markers, which is also a
genome wide association study (GWAS) gene associated with CKD, was Myh9. Myh9 expression is upregulated
specifically in injured and failed repair cell clusters, and is found in low levels in healthy and repairing proximal
tubule cells. This gene encodes for nonmuscle myosin IIA (NMIIA), which plays an important role in cell shape,
adhesion, migration, and cytokinesis. It interacts directly with actin, creating a stable cytoskeletal network. Drastic
changes in Myh9 expression may translate into changes in NMIIA abundance that could alter the regulation of
downstream signaling, contributing to phenotypes characteristic of AKI. Therefore, I hypothesize that sexually
dimorphic expression of Myh9 in the kidney and sex-specific mechanisms of NMIIA activation contribute to the
renoprotection of female sex. Preliminary data suggests that female C57BL/6J mice at baseline have higher
expression of Myh9 than males, potentially indicating that females have developed mechanisms for decreasing
activity of NMIIA through downregulation of ischemia responsive kinases. This proposal will investigate these
expression changes in males and females along the injury time course following Bi-IRI using single nuclei
sequencing and spatial transcriptomics. Additionally, the relationship between ischemia and NMIIA function will
be investigated using gold standard biochemical techniques in in vivo and in vitro cell models. Ultimately, this
proposal will generate a transcriptomic atlas of sex differences in AKI and illuminate the role of NMIIA in the
disease progression of AKI to CKD, potentially identifying a new sex-specific therapeutic target.
抽象的
驱动急性肾损伤(AKI)进展为慢性肾病(CKD)的细胞机制
没有被很好地理解。 AKI 是多种原因引起的肾功能突然下降
结构和功能损坏。 AKI 的患病率在美国迅速增加,并呈现出
全世界的医疗保健负担。迄今为止,尚无有效的疗法来缓解促炎性炎症
以及损伤引起的纤维化表型。有趣的是,它最近得到了流行病学的支持
数据表明,女性是 AKI 进展为 CKD 的保护因素。利用性别比较
缺血性损伤的具体机制对于识别新颖、有效的治疗方法具有令人难以置信的潜力
目标。因此,我将采用单核 RNA 和 ATAC 测序,以及空间测序
转录组学可生成双侧缺血女性损伤时间过程的多模式图谱
再灌注损伤(Bi-IRI)。最近,使用 Bi-IRI 在雄性小鼠中发现了一种新的细胞状态
单核RNA测序。这些细胞被称为近端小管修复失败细胞(FR-PTC)
恢复途径中的死胡同,可能会导致增殖、纤维化和
损伤后使肾组织恶化的炎症。这些 FR-PTC 表现出差异表达的特征
健康和修复细胞状态所特有的基因。这些遗传标记之一,也是
全基因组关联研究(GWAS)与 CKD 相关的基因是 Myh9。 Myh9 表达上调
特别是在受损和失败的修复细胞簇中,并且在健康和修复的近端细胞中含量较低
肾小管细胞。该基因编码非肌肉肌球蛋白 IIA (NMIIA),它在细胞形状中发挥重要作用,
粘附、迁移和胞质分裂。它直接与肌动蛋白相互作用,形成稳定的细胞骨架网络。激烈的
Myh9 表达的变化可能会转化为 NMIIA 丰度的变化,从而改变对
下游信号传导,有助于形成 AKI 的表型特征。因此,我推测性行为
Myh9 在肾脏中的二态性表达和 NMIIA 激活的性别特异性机制有助于
对女性性的肾脏保护。初步数据表明,雌性 C57BL/6J 小鼠在基线时具有更高的
Myh9 的表达高于男性,这可能表明女性已经形成了降低 Myh9 表达的机制。
通过下调缺血反应性激酶来调节 NMIIA 的活性。本提案将调查这些
使用单核 Bi-IRI 后,男性和女性在损伤时间过程中的表达变化
测序和空间转录组学。此外,缺血与 NMIIA 功能之间的关系将
使用金标准生化技术在体内和体外细胞模型中进行研究。最终,这
该提案将生成 AKI 性别差异的转录组图谱,并阐明 NMIIA 在 AKI 中的作用
AKI 到 CKD 的疾病进展,有可能确定新的性别特异性治疗靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eryn E. Dixon其他文献
Eryn E. Dixon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eryn E. Dixon', 18)}}的其他基金
Role of nonmuscle myosin IIA in sex-dependent failed repair mechanisms in acute kidney injury
非肌肉肌球蛋白 IIA 在急性肾损伤性别依赖性失败修复机制中的作用
- 批准号:
10418648 - 财政年份:2021
- 资助金额:
$ 6.87万 - 项目类别:
相似国自然基金
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Tenascin-X对急性肾损伤血管内皮细胞的保护作用及机制研究
- 批准号:82300764
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
- 批准号:82370084
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
KIF5B调控隧道纳米管介导的线粒体转运对FLT3-ITD阳性急性髓系白血病的作用机制
- 批准号:82370175
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
PHF6突变通过相分离调控YTHDC2-m6A-SREBP2信号轴促进急性T淋巴细胞白血病发生发展的机制研究
- 批准号:82370165
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Unanticipated roles of C5aR1 Signaling Leading from Acute to Chronic Kidney Disease
C5aR1 信号转导从急性肾病到慢性肾病的意外作用
- 批准号:
10591053 - 财政年份:2023
- 资助金额:
$ 6.87万 - 项目类别:
Rac1 and the actin cytoskeleton in renal tubular repair
Rac1 和肌动蛋白细胞骨架在肾小管修复中的作用
- 批准号:
10739610 - 财政年份:2023
- 资助金额:
$ 6.87万 - 项目类别:
New mouse model of cisplatin-induced AKI and development of prevention therapy
顺铂诱发 AKI 的新小鼠模型及预防治疗的进展
- 批准号:
10671738 - 财政年份:2021
- 资助金额:
$ 6.87万 - 项目类别:
Role of nonmuscle myosin IIA in sex-dependent failed repair mechanisms in acute kidney injury
非肌肉肌球蛋白 IIA 在急性肾损伤性别依赖性失败修复机制中的作用
- 批准号:
10418648 - 财政年份:2021
- 资助金额:
$ 6.87万 - 项目类别:
New mouse model of cisplatin-induced AKI and development of prevention therapy
顺铂诱发 AKI 的新小鼠模型及预防治疗的进展
- 批准号:
10297669 - 财政年份:2021
- 资助金额:
$ 6.87万 - 项目类别: